|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 1.780 SEK | -5.77% |
|
-12.23% | -62.96% |
| 08-27 | Oncopeptides AB, Q2 2026 Earnings Call, Aug 27, 2026 | |
| 08-27 | Oncopeptides AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ONCO | Delayed | |
CBOE
| ONCOs | Real-time | |
Börse Stuttgart
| OND | Delayed | |
Deutsche Boerse AG
| OND | Delayed | |
London S.E.
| 0RN4 | Delayed | |
CBOE
| 0RN4 | Real-time | |
Boerse Muenchen
| OND | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bearish |
| Resistance | 2.05 | 2.05 | 2.77 |
| Spread/Res. | -13.17% | -13.17% | -35.74% |
| Spread/Supp. | +1.19% | +13.38% | +40.49% |
| Support | 1.759 | 1.57 | 1.267 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ONCO Stock
- Charts Oncopeptides AB
Select your edition
All financial news and data tailored to specific country editions

















